Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic
Charles Whittaker, Gregory Barnsley, Daniela Olivera Mesa, View ORCID ProfileDaniel J Laydon, Chee Wah Tan, Feng Zhu, Rob Johnson, Patrick Doohan, Gemma Nedjati-Gilani, Peter Winskill, Alexandra B. Hogan, Arminder Deol, Christinah Mukandavire, Katharina Hauck, David Chien Boon Lye, Lin-Fa Wang, View ORCID ProfileOliver J. Watson, Azra C Ghani
doi: https://doi.org/10.1101/2024.08.12.24311730
Charles Whittaker
1MRC Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
Gregory Barnsley
2London School of Hygiene and Tropical Medicine, London, UK
Daniela Olivera Mesa
1MRC Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
Daniel J Laydon
1MRC Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
Chee Wah Tan
3Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
4Infectious Diseases Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Feng Zhu
3Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
Rob Johnson
1MRC Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
Patrick Doohan
1MRC Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
Gemma Nedjati-Gilani
1MRC Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
Peter Winskill
1MRC Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
Alexandra B. Hogan
1MRC Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
5School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia
Arminder Deol
6Coalition for Epidemics Preparedness Innovations, Oslo, Norway
Christinah Mukandavire
6Coalition for Epidemics Preparedness Innovations, Oslo, Norway
Katharina Hauck
1MRC Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
David Chien Boon Lye
7National Centre for Infectious Diseases, Singapore
8Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore
9Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
10Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Lin-Fa Wang
3Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
11SingHealth Duke-NUS Global Health Institute, Singapore
Oliver J. Watson
1MRC Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
Azra C Ghani
1MRC Centre for Global Infectious Disease Analysis & Abdul Latif Jameel Institute for Disease and Emergency Analytics, School of Public Health, Imperial College London, London, UK
Data Availability
The modelling framework, along with all relevant data and code required to reproduce the analyses presented in this manuscript are freely available in Github repository (https://github.com/mrc-ide/diseaseX_modelling).
Posted August 12, 2024.
Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic
Charles Whittaker, Gregory Barnsley, Daniela Olivera Mesa, Daniel J Laydon, Chee Wah Tan, Feng Zhu, Rob Johnson, Patrick Doohan, Gemma Nedjati-Gilani, Peter Winskill, Alexandra B. Hogan, Arminder Deol, Christinah Mukandavire, Katharina Hauck, David Chien Boon Lye, Lin-Fa Wang, Oliver J. Watson, Azra C Ghani
medRxiv 2024.08.12.24311730; doi: https://doi.org/10.1101/2024.08.12.24311730
Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic
Charles Whittaker, Gregory Barnsley, Daniela Olivera Mesa, Daniel J Laydon, Chee Wah Tan, Feng Zhu, Rob Johnson, Patrick Doohan, Gemma Nedjati-Gilani, Peter Winskill, Alexandra B. Hogan, Arminder Deol, Christinah Mukandavire, Katharina Hauck, David Chien Boon Lye, Lin-Fa Wang, Oliver J. Watson, Azra C Ghani
medRxiv 2024.08.12.24311730; doi: https://doi.org/10.1101/2024.08.12.24311730
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (197)
- Cardiovascular Medicine (2881)
- Dermatology (247)
- Emergency Medicine (432)
- Epidemiology (12617)
- Forensic Medicine (10)
- Gastroenterology (812)
- Genetic and Genomic Medicine (4483)
- Geriatric Medicine (409)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1059)
- Hematology (378)
- HIV/AIDS (910)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4245)
- Nursing (228)
- Nutrition (622)
- Oncology (2225)
- Ophthalmology (633)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (490)
- Pediatrics (1182)
- Primary Care Research (487)
- Public and Global Health (6829)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (376)
- Surgery (475)
- Toxicology (60)
- Transplantation (206)
- Urology (176)